Details for Patent: 11,896,567
✉ Email this page to a colleague
Which drugs does patent 11,896,567 protect, and when does it expire?
Patent 11,896,567 protects COMBOGESIC IV and is included in one NDA.
This patent has thirty-three patent family members in twenty-six countries.
Drugs Protected by US Patent 11,896,567
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | METHOD OF TREATING MILD TO MODERATE PAIN IN ADULTS | ⤷ Subscribe | ||||
Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | METHOD OF TREATING MODERATE TO SEVERE PAIN IN ADULTS AS AN ADJUNCT TO OPIOID ANALGESICS | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,896,567
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011324137 | ⤷ Subscribe | |||
Brazil | 112013010829 | ⤷ Subscribe | |||
Canada | 2814057 | ⤷ Subscribe | |||
Chile | 2013001250 | ⤷ Subscribe | |||
China | 103298464 | ⤷ Subscribe | |||
China | 107519159 | ⤷ Subscribe | |||
Colombia | 6771406 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |